Aegis Capital Starts Recro Pharma (REPH) at Buy

November 14, 2016 7:45 AM EST
Get Alerts REPH Hot Sheet
Price: $7.15 +0.70%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 22 | New: 54
Trade REPH Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Aegis Capital initiated coverage on Recro Pharma (NASDAQ: REPH) with a Buy rating and a price target of $21.00.

For an analyst ratings summary and ratings history on Recro Pharma click here. For more ratings news on Recro Pharma click here.

Shares of Recro Pharma closed at $8.04 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Add Your Comment